Lannett readying to ship two new generics
PHILADELPHIA — Lannett Co. has received Food and Drug Administration approvals for a pair of new generic products. Abbreviated New Drug Applications (ANDAs) have been approved for potassium chloride extended-release capsules, in strengths of 8 mEq and 10 mEq, and for temozolomide capsules, in dosages of 5 mg, 20 mg, 100 mg, 140 mg, 180
